Diabetic retinopathy screening and monitoring of early stage disease in general practice: design and methods

Askew, Deborah A., Crossland, Lisa, Ware, Robert S., Begg, Stephen, Cranstoun, Peter, Mitchell, Paul and Jackson, Claire L. (2012) Diabetic retinopathy screening and monitoring of early stage disease in general practice: design and methods. Contemporary Clinical Trials, 33 5: 969-975. doi:10.1016/j.cct.2012.04.011


Author Askew, Deborah A.
Crossland, Lisa
Ware, Robert S.
Begg, Stephen
Cranstoun, Peter
Mitchell, Paul
Jackson, Claire L.
Title Diabetic retinopathy screening and monitoring of early stage disease in general practice: design and methods
Journal name Contemporary Clinical Trials   Check publisher's open access policy
ISSN 1551-7144
1559-2030
Publication date 2012-09
Sub-type Article (original research)
DOI 10.1016/j.cct.2012.04.011
Open Access Status Not Open Access
Volume 33
Issue 5
Start page 969
End page 975
Total pages 7
Place of publication Philadelphia, PA United States
Publisher Elsevier
Language eng
Abstract Diabetic retinopathy is the leading cause of preventable blindness in Australians younger than 60 years, mainly from the development of diabetic macular oedema and the sequelae of advanced proliferative diabetic retinopathy. However, early detection and subsequent treatment of diabetic retinopathy, as recommended in Australian national guidelines, can prevent nearly all cases of severe vision loss and blindness, but few people achieve this goal. This paper describes the design and methods of an open controlled trial that aims to assess the feasibility, acceptability, and relative costs and benefits of identification and management of early stages of diabetic retinopathy in primary care, with tele-ophthalmic support and education. A mix of urban, regional and rural general practices across Queensland, Australia are participating in this study, with control practices matched to intervention practices by geographic location, size, patient profile, and shared hospital referral pathways. Outcome measures include the quality of the retinal photographs, the general practitioners' diagnostic accuracy, the acceptability of this intervention to patients, general practice staff and ophthalmologists, screening rates, appropriate monitoring of early stage disease, and the cost-effectiveness of this model, compared to usual care. If proven to be effective, this model of diabetic retinopathy screening and early disease stage monitoring has the potential to improve access to appropriate care. The trial is registered with the Australian New Zealand Clinical Trials Registry (ACTRN 00336192).
Keyword Type 2 Diabetes
Diabetic retinopathy
Primary care
Screening
Tele-medicine
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Discipline of General Practice Publications
School of Public Health Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 11 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 14 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 01 Apr 2016, 11:59:33 EST by Lisa Crossland on behalf of Discipline of General Practice